Stricter Chinese scrutiny of offshore vehicles a blow for tech and biotech IPO candidates

    Stricter Chinese scrutiny of offshore vehicles a blow for tech and biotech IPO candidates

    US dollar-denominated funds could face more hurdles when investing in Chinese tech and biotech companies as Beijing adopts a stricter approach to companies seeking listings via offshore incorporated vehicles. Indicative of Chinese regulators’ caution in overseeing sensitive industries, industry sources say the move ensures that any sale of assets does not escape regulatory scrutiny. And…

    Read More
    Tong Ren Tang healthcare unit pulls Hong Kong IPO scheduled for Monday

      Tong Ren Tang healthcare unit pulls Hong Kong IPO scheduled for Monday

      Beijing Tong Ren Tang Healthcare Investment, a provider of healthcare services based on traditional Chinese medicine, postponed its Hong Kong initial public offering (IPO) on Friday, citing “prevailing market conditions” and other factors. The company was one of six trading debuts slated for Monday, including an exchange-traded fund (ETF) and firms involved in AI and…

      Read More
      China and Hong Kong should relax biotech listing rules, venture capitalist says

        China and Hong Kong should relax biotech listing rules, venture capitalist says

        Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture capitalist Nisa Leung said. “Besides artificial intelligence, Premier Li Qiang also highlighted biomedicine in the ‘two sessions’ annual government work report,” said Leung, a managing…

        Read More
        Breaking | China places former stocks regulator Yi Huiman under probes for disciplinary breaches

        Breaking | China places former stocks regulator Yi Huiman under probes for disciplinary breaches

        Yi Huiman, the former regulator of China’s equities market, is being investigated for disciplinary breaches, as the country’s long-standing anti-graft campaign extends into all corners of the financial industry, from banking to the stock market. Yi, the chairman of the China Securities Regulatory Commission (CSRC) from January 2019 to February 2024, has been detained by…

        Read More